Hosted on MSN25d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).
AOL1mon
FDA-approved nasal spray for severe depression can lead to remission
Major depression has one of the highest economic burdens of any psychiatric disorder,” he pointed out. Now, the FDA has also approved Spravato for treating adults with MDD who have not responded ...
Neuroscience News18h
FDA Approves Adaptive DBS for Parkinson’s Patients
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Rolling Out2d
Study reveals psilocybin effectiveness in depression
Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...
GoodNewsNetwork9d
FDA Approves Opioid-free Pain Medication That Finally Delivers Relief Without Addiction
The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...